Big Pharma and American Psychiatry

2008/04/01 by Steven S. Sharfstein
Pharmacology, Toxicology and Pharmaceutics · #Pharmaceutical industry and healthcare

paper · doi:10.1097/nmd.0b013e31816a4380

Abstract

Clinical Professor and Vice Chair, Department of Psychiatry, University of Maryland School of Medicine, Baltimore, Maryland; President and CEO, the Sheppard and Enoch Pratt Health System, Towson, Maryland. Send reprint requests to Steven S. Sharfstein, MD, The Sheppard and Enoch Pratt Health System, 6501 North Charles St., Towson, MD 21204. E-mail: [email protected].

Related

• Diagnostic and Statistical Manual of Mental Disorders, 5th Edition, and Clinical Utility
• Managed Behavioral Health Care in the Public Sector
• Notes from the Front: A Psychiatrist Joins Medical Students and Their First Patients
• Time and the Art of Psychopharmacology
• Parity Redux